Michael Gaertner, Keith Parr, James Peterka, David Abramowitz, Wasim Bleibel and Timothy Peterson (all of Chicago) successfully represented Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited by securing a ruling after a bench trial that Zydus’s proposed generic version of Shire Development LLC’s ulcerative colitis drug Lialda would not infringe Shire’s U.S. Patent No. 6,773,720.
To read the complete article, click here (subscription may be required).
Sign up for our newsletter and get the latest to your inbox.